Combination blockade of KLRG1 and PD-1 promotes immune control of local and disseminated cancers

Checkpoint blockade therapy is effective against many cancers; however, new targets need to be identified to treat patients who do not respond to current treatment or demonstrate immune escape. Here, we showed that blocking the inhibitory receptor Killer cell lectin-like receptor G1 (KLRG1) enhances...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Oncoimmunology
Main Authors: Tata, Angela, Dodard, Garvin, Fugère, Céline, Leget, Corinne, Ors, Mélody, Rossi, Benjamin, Vivier, Eric, Brossay, Laurent
Formato: Artigo
Idioma:Inglês
Publicado em: Taylor & Francis 2021
Assuntos:
Original Research
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC8208121/
https://ncbi.nlm.nih.gov/pubmed/34188973
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/2162402X.2021.1933808
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados